| Literature DB >> 26089890 |
Gian Pietro Emerenziani1, Maria Chiara Gallotta1, Marco Meucci2, Luigi Di Luigi3, Silvia Migliaccio3, Lorenzo Maria Donini4, Felice Strollo5, Laura Guidetti1.
Abstract
In obese diabetic subjects, a correct life style, including diet and physical activity, is part of a correct intervention protocol. Thus, the aim of this study was to evaluate the effects of aerobic training intervention, based on heart rate at aerobic gas exchange threshold (AerTge), on clinical and physiological parameters in obese elderly subjects with type 2 diabetes (OT2DM). Thirty OT2DM subjects were randomly assigned to an intervention (IG) or control group (CG). The IG performed a supervised aerobic exercise training based on heart rate at AerTge whereas CG maintained their usual lifestyle. Anthropometric measures, blood analysis, peak oxygen consumption ([Formula: see text]), metabolic equivalent (METpeak), work rate (WRpeak), and WRAerTge were assessed at baseline and after intervention. After training, patients enrolled in the IG had significantly higher (P < 0.001) [Formula: see text], METpeak, WRpeak, and WRAerTge and significantly lower (P < 0.005) weight, BMI, %FM, and waist circumference than before intervention. Both IG and CG subjects had lower glycated haemoglobin levels after intervention period. No significant differences were found for all the other parameters between pre- and posttraining and between groups. Aerobic exercise prescription based upon HR at AerTge could be a valuable physical intervention tool to improve the fitness level and metabolic equilibrium in OT2DM patients.Entities:
Year: 2015 PMID: 26089890 PMCID: PMC4452101 DOI: 10.1155/2015/695297
Source DB: PubMed Journal: Int J Endocrinol ISSN: 1687-8337 Impact factor: 3.257
Anthropometric measures, lipid profile, and glycated haemoglobin for the intervention group (IG) and the control group (CG) at baseline and after 3-month period.
| IG ( | CG ( | |||
|---|---|---|---|---|
| T0 | T3 | T0 | T3 | |
| Weight (kg) | 87.6 ± 19.5 | 85.0 ± 17.8* | 87.0 ± 22.6 | 87.0 ± 22.1 |
| BMI (kg/m2) | 33.6 ± 7.7 | 32.6 ± 7.1* | 33.0 ± 5.4 | 32.9 ± 5.3 |
| Fat mass (%) | 31.5 ± 10.4 | 29.5 ± 9.5* | 32.5 ± 4.2 | 31.1 ± 7.1 |
| Abdominal circumference (cm) | 117.8 ± 17.5 | 115.6 ± 15.9* | 107.0 ± 12.2 | 105.4 ± 12.8 |
| Glycated haemoglobin (mmol/mol) | 49.9 ± 8.3 | 45.3 ± 7.3* | 53.0 ± 12.2 | 45.0 ± 5.6* |
| Total cholesterol (mg/dL) | 210.6 ± 57.9 | 217.1 ± 56.9 | 163.8 ± 33.1 | 162.0 ± 37.6 |
| HDLC (mg/dL) | 46.6 ± 16.2 | 48.7 ± 13.2 | 43.8 ± 12.9 | 46.7 ± 13.0 |
| LDLC (mg/dL) | 122.9 ± 51.6 | 136.3 ± 40.1 | 96.0 ± 51.2 | 99.3 ± 22.6 |
BMI: body mass index; HDLC: high density lipoprotein cholesterol; LDLC: low density lipoprotein cholesterol.
∗ P < 0.05 versus T0.
Physiological parameters for the intervention group (IG) and the control group (CG) at baseline and after 3-month period.
| IG ( | CG ( | |||
|---|---|---|---|---|
| T0 | T3 | T0 | T3 | |
|
| 15.9 ± 3.0 | 18.5 ± 3.2* | 18.6 ± 4.2 | 17.9 ± 5.7 |
| METpeak | 4.5 ± 0.8 | 5.3 ± 1* | 5.3 ± 1.2 | 5.1 ± 1.6 |
| WRpeak (W) | 65.7 ± 25.9 | 78.6 ± 26.1* | 96.0 ± 23.0 | 88.3 ± 20.0 |
| %HRmax (%) | 77.1 ± 9.5 | 77.9 ± 7.9 | 79.0 ± 5.8 | 80.3 ± 7.5 |
| % | 57.7 ± 11.9 | 51.7 ± 11.6 | 58.1 ± 12.1 | 59.9 ± 16.5 |
| %HRmax at AerTge (%) | 57.7 ± 8.3 | 56.1 ± 8.0 | 60.0 ± 7.6 | 60.0 ± 6.7 |
| %HRR at AerTge (%) | 24.4 ± 12.2 | 21.6 ± 9.8 | 18.9 ± 4.7 | 18.4 ± 7.2 |
| WR at AerTge (w) | 20.4 ± 4.7 | 28.0 ± 8.2* | 20.8 ± 9.5 | 23.3 ± 0.3 |
| ΔHR (bpm) | 21.5 ± 11.6 | 18.9 ± 9.5 | 14.2 ± 3.9 | 14.3 ± 7.7 |
| MET at AerTge | 2.6 ± 0.6 | 2.6 ± 0.6 | 3.1 ± 0.6 | 2.9 ± 0.6 |
O2peak: peak oxygen uptake; MET: metabolic equivalent; WRpeak: peak work rate.
HRmax: maximum heart rate; HRR: heart rate reserve; ΔHR: heart rate at AerTge-heart rate at rest.
∗ P < 0.05 versus T0.
Figure 1Glycated hemoglobin (HbA1c) before and after 3-month intervention period in control (CG) and intervention groups (IG).